UFPT · NASDAQ · Medical - Devices

UFP Technologies (UFPT)

Designs and manufactures custom single-use medical devices, sterile packaging, and engineered components.

$283.64
vs last close+1.95 (+0.69%)
Loading prices…

UFP Technologies, Inc.UFPT
Health Care

Develops and manufactures custom single-use and single-patient devices, sterile packaging, and engineered components through outsourced design and production programs. Medical markets drive most sales, while the two largest customers together account for nearly half of revenue.

Designs, develops, and manufactures custom single-use and single-patient devices through MedTech, alongside non-medical work in Advanced Components. Medical offerings span interventional and surgical devices, sterile packaging, infection-prevention and robotic-surgery drapes, orthopedic and wound-care products, wearable components, and patient-handling systems. Advanced Components supplies engineered foam, film, plastic, adhesive, and fabric parts for aerospace, defense, automotive, and industrial customers.

Combines materials conversion, precision molding and welding, cleanroom production, prototype development, and commercial-scale assembly across the United States, Ireland, Singapore, Mexico, Costa Rica, and the Dominican Republic. Customer-specific engineering and access to specialized materials support long production programs for device makers. Most sales come from regulated medical markets, and the two largest customers together account for nearly half of revenue.

Company facts

CEOMitchell C. Rock
ListedDec 17, 1993
ExchangeNASDAQ
HeadquartersNewburyport, MA
CountryUnited States
Employees4,846
CIK0000914156
ISINUS9026731029

Market cap$2.18B
EPS (ttm)$9.27
P/E (ttm)30.39
ROE16.7%
P/B4.71
P/S3.45
Dividend yieldDiv yield
Beta1.31vs XLV 0.71

Price target$298.00+5.8%Average of 2 analysts
ConsensusBuy2 of 2 analysts
Ratings

Target rangeAs of Sep 21, 2026

Latest analyst notes

No analyst notes in the last 24 months.

Next report
Nov 2, 26
in 41 days
EPS estimate
$2.63
Revenue estimate
$166.9M
Fiscal quarter
Q3 FY26

EPSReportedEstimate

Feb '25May '25Aug '25Nov '25Feb '26May '26Aug '26Nov '26
Reported$2.46$2.47$2.50$2.39$2.44$2.27$2.69Pending
Estimate$1.98$2.05$2.29$2.22$2.26$2.18$2.31$2.63
Surprise+24.2%+20.5%+9.2%+7.7%+8.0%+4.1%+16.5%

RevenueReportedEstimate

Feb '25May '25Aug '25Nov '25Feb '26May '26Aug '26Nov '26
Reported$144.1M$148.1M$151.2M$154.6M$148.9M$154.2M$174.0MPending
Estimate$141.7M$145.1M$152.4M$149.1M$149.1M$154.8M$159.4M$166.9M
Surprise+1.7%+2.1%−0.8%+3.7%−0.1%−0.4%+9.1%
Estimate$2.63
ReportedDue Nov 2, 2026
Estimate$166.9M
ReportedDue Nov 2, 2026
View details

Debt to equity29.50%
Current ratio300.00%

ProfitabilityRevenueNet incomeNet margin

Q3 FY24Q4 FY24Q1 FY25Q2 FY25Q3 FY25Q4 FY25Q1 FY26Q2 FY26
Revenue$145.2M$144.1M$148.1M$151.2M$154.6M$148.9M$154.2M$174.0M
Net income$16.4M$16.4M$17.2M$17.2M$16.4M$17.6M$17.5M$20.9M
Net margin11.3%11.4%11.6%11.4%10.6%11.8%11.3%12.0%

GrowthOperating income

Q3 FY24Q4 FY24Q1 FY25Q2 FY25Q3 FY25Q4 FY25Q1 FY26Q2 FY26
Operating income$24.8M$22.3M$23.1M$24.3M$23.4M$21.5M$23.3M$28.1M
YoY growth+64.6%+74.8%+45.2%+35.5%−5.6%−3.4%+0.9%+15.5%

Balance sheet, Jun 30, 2026Cash & short-term investments $9.0M · Total debt $136.3M · Total assets $681.9M · Shareholders' equity $462.4M

Revenue
$174.0M
Operating income
$28.1M
Net income
$20.9M
View details

No dividends on record.

Institutions123.80%9.59M shares
284 holders · as of Jun 30, 2026
Insiders3.73%288.6K shares
13 holders · as of Aug 27, 2026
Strategic holders4.77%369.8K shares
1 holder · as of Sep 19, 2017
Adds to132.30%

7.75M company shares as of Sep 22, 2026 · institutions as of Jun 30, 2026 · holders as of their latest filing

These groups come from separate filings that can overlap, so they add to 132.30%; nothing is left for Other.

Top shareholders13F · 13D/G · Form 4

HolderStakeSharesDate
BlackRock, Inc.Institution
14.74%1.14Mas of Jun 30, 2026
Congress Asset Management Co /MAInstitution
8.88%687,439as of Jun 30, 2026
Wasatch Advisors LPInstitution
8.82%683,262as of Jun 30, 2026
Neuberger Berman Group LLCInstitution
6.93%537,038as of Jun 30, 2026
Wellington Trust Company, National Association Multiple Common Trust Funds Trust, Micro Cap Equity PStrategic
4.77%369,845filed Sep 19, 2017

Insider tradesForm 4

DateInsiderRoleSharesAvg price
Aug 25, 2026Marc D. Kozindirector−7,000$304.50
Aug 18, 2026Symeria Hudsondirector−298$319.11
Aug 14, 2026Symeria Hudsondirector−1,926$324.58
Aug 13, 2026Cynthia L. Feldmanndirector−1,000$324.26
Aug 10, 2026R. Jeffrey Baillydirector, officer: Executive Chairman−13,011$316.13
View details

  • Integer

    Medtech CDMO peer across outsourced device components and assemblies

  • Jabil

    Scaled healthcare manufacturing alternative for regulated OEM programs

  • Flex

    End-to-end manufacturing rival in medical devices and drug delivery

  • Nordson

    Medical components and interventional systems overlap with UFP MedTech

  • AptarGroup

    Pharma packaging and drug-delivery component peer

  • Amcor

    Large healthcare packaging rival after Berry merger

  • Avient

    Specialty polymer materials peer for medical-device inputs

Compare

CompanyPriceChange
UFP Technologies$283.64+0.69%$2.18B30.428.13.5+15.1%
Integer$126.41+0.02%$4.29B34.519.02.3−2.6%
Jabil$307.78+1.35%$31.82B37.919.50.9+11.8%
Flex$114.58+2.66%$41.23B43.122.01.4+20.6%
Nordson$318.95+1.46%$17.51B31.825.25.9+10.3%
AptarGroup$125.36+1.59%$7.88B22.321.12.0+6.3%
Amcor$43.03+2.08%$19.49B9.9+25.9%
Avient$41.20+1.88%$3.71B21.912.61.1+5.8%
Median33.219.51.7+10.3%